Citation Impact
Citing Papers
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
1999
Emotion-regulation strategies across psychopathology: A meta-analytic review
2009 Standout
Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs
2000 StandoutNobel
Chlorpromazine versus placebo for schizophrenia
2007
A Randomized, Placebo-Controlled Dose-Comparison Trial of Haloperidol for Psychosis and Disruptive Behaviors in Alzheimer’s Disease
1998
Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: What depression has in common with impulsive aggression.
2008
Childhood and Adolescent Depression: A Review of the Past 10 Years. Part I
1996 Standout
Drugs and Falls in Older People: A Systematic Review and Meta‐analysis: I. Psychotropic Drugs
1999 Standout
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 Standout
Psychedelics
2016 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
Role of GABAA Receptors in the Regulation of Sleep: Initial Sleep Responses to Peripherally Administered Modulators and Agonists
1999
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
1995
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
1997
Executive Functions and Developmental Psychopathology
1996 Standout
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
2003 Standout
The Effects of Amantadine and Pemoline on Cognitive Functioning in Multiple Sclerosis
1996
The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs
2014
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Measuring inconsistency in meta-analyses
2003 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
The Antiphospholipid Syndrome
2002 Standout
Effects of antidepressants on cognitive functions: A review
1995
An Overview of Heart Rate Variability Metrics and Norms
2017 Standout
Antipsychotics and QT prolongation
2003
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
2013 Standout
A Randomized Trial of Dementia Care in Nursing Homes
1996
Genetic Factors in Child Psychiatric Disorders—II. Empirical Findings
1990
Psychiatric Aspects of Impulsivity
2001 Standout
Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia
1990
ALZHEIMER'S DISEASE AND RELATED DISORDERS
2001
Fluvoxamine in the treatment of demented elderly patients: a double‐blind, placebo‐controlled study
1992
Recurrent miscarriage
2006 Standout
Alzheimer's Disease
2004 Standout
An open, noncomparative study of amoxapine in borderline disorders
1989
Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis
1995
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Mild cognitive impairment as a diagnostic entity
2004 Standout
Estrogen Actions in the Central Nervous System1
1999 Standout
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
1993
Effects of estrogen on the basal ganglia
1986
A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics
1975
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Chlorpromazine versus placebo for schizophrenia
2014
Acute Extrapyramidal Syndromes in Neuroleptic-Treated Elders: A Pilot Study
1991
Alzheimer's disease
1998 Standout
A Review of REM Sleep Deprivation
1975
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
2006
Delusions in newly admitted residents of nursing homes
1990
Iprindole and Imipramine in Non-Psychotic Depressed Out-Patients
1973
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
1987 Standout
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Dopamine and the pharmacology of schizophrenia: The state of the evidence
1974
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Haloperidol versus chlorpromazine for schizophrenia
2008
Variations in circadian heart rate in psychiatric disorders: theoretical and practical implications
2013
Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients
1990
The Pharmacology of Tardive Dyskinesias
1973
A New Depression Scale Designed to be Sensitive to Change
1979 Standout
From motivation to action: Functional interface between the limbic system and the motor system
1980 Standout
A possible common mechanism of action of antidepressant treatments
1976
A Two-Year Longitudinal Study of Cognitive Function in Normal Aging and Alzheimer's Disease
1993
About Sleep's Role in Memory
2013 Standout
Prolonged bed rest in the treatment of idiopathic cardiomyopathy
1972
The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness
1987
Effect of Iprindole on Amine Uptake in Man
1972
Does dopamine play a role in schizophrenia?
1977 StandoutNobel
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
The Efficacy of Antidepressant Drugs
1974
Some current problems related to the mode of action of antidepressant drugs
1981 StandoutNobel
Haloperidol versus placebo for schizophrenia
2013
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
The Dopamine Hypothesis of Schizophrenia: A Review*
1976
Behavioural despair in rats: A new model sensitive to antidepressant treatments
1978 Standout
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder
2002 Standout
The Neuropsychiatric Inventory
1997 Standout
Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia
2008
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Sex differences in amphetamine-elicited rotational behavior and the lateralization of striatal dopamine in rats
1980
Duloxetine versus other anti-depressive agents for depression
2012
Dopamine Receptors: From Structure to Function
1998 Standout
Industry sponsorship and research outcome
2017 Standout
Mode of action of antidepressant drugs
1978
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Works of Ban Ta being referenced
A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.
1977
Desipramine plasma levels and therapeutic response.
1978
Psychometric tests in evaluation of brain pathology, response to drugs.
1970
Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
1974
A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
1984
Protrptyline in the treatment of chronic schizophrenic patients.
1970
Lack of indication for use of antiparkinson medication. A follow-up study.
1971
[THE PSYCHOPHYSIOLOGICAL EFFECTS OF METHYLDOPA].
1963
Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of change.
1976
Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification.
1984
The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
1967
Pimozide in the treatment of chronic schizophrenic patients.
1970
The effect of hypnotics on rapid eye movement (REM).
1968
Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
1968
A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients.
1970
Psychological tests: practice effect in geriatric patients.
1968
THE EFFECT OF PHENOTHIAZINES ON THE ELECTROCARDIOGRAM.
1964
Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
1982
Comprehesiven clinical studies with thiothixene.
1975
Amoxapine and viloxazine: review of the literature with special reference to clinical studies.
1979
Sex differences in long-term adverse effects of phenothiazines.
1974
Negative findings with megavitamins in schizophrenic patients: preliminary report.
1977
Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
1972
Effects of psychoactive drugs on conflict avoidance behavior in human subjects.
1971
A preliminary investigation of WY-3263 versus amitriptyline in depressions.
1968
Treatment of acute and chronic psychoses with haloperidol: review of clinical results.
1969
Affective disorders: biological aspects.
1985
Systematic clinical studies with trazodone: methodological aspects.
1973
Doxepin in the treatment of psychoneurotic inpatients.
1970
Comparative pharmacotherapy of the aging psychotic patient.
1967